I can address that question.
In the United States, we have a veterans administration that awards disability claims for conditions such as post-traumatic stress disorder and the effects of traumatic brain injury.
It's my experience that a fair number of veterans who have been suffering what are primarily effects from mefloquine are able to be compensated to some degree through awards for these other conditions. It is possible that some veterans have been essentially misdiagnosed with post-traumatic stress disorder. That's an academic subject whether it's a correct diagnosis or not in the presence of mefloquine effects. Others have been mistakenly attributed to traumatic brain injury.
Where veterans face more difficulties, though, is when mefloquine toxicity symptoms manifest, for example, primarily as a psychotic disorder, or primarily as a panic disorder, or what is sometimes called an adjustment disorder. There may be less willingness on the part of the adjudicators to attribute those conditions to combat. Of course, this speaks to the fact that we don't yet have a diagnosis for what is, I believe, a genuine syndrome.
If we ever do have formal diagnostic criteria and formal recognition in the medical community for this syndrome, then, of course, that syndrome would be what is compensated in the United States. I think many more years of research are necessary in order to ensure that we can make that distinction with clarity.